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Background
MRgFUS represent a new therapeutic option for the
non-surgical management of osteoid osteoma. The site
of the lesion is the most significant limitation of use of
this technique.
Purpose of this study is to compare the clinical and mor-
phological two years after the procedure, of the treatment
of 28 osteoid osteomas with Magnetic Resonance guided
Focus Ultrasound Surgery (MRgFUS) versus the treatment
with Radiofrequency termoablation (RF).
Methods and materials
From March 2011 we treated 28 osteoid osteomas, 13
using MRgFUS (ExAblate InSightech, Israel) and 15 using
RF (LeVeen Needle Electrode Boston Scientific - USA).
The osteoid osteomas treated with MRgFUS were located
in the femour (n.9), tibia (n.3) and in the talus (n. 1). The
lesions treated with RFs were located in the femour (n. 9),
talus (n.2), vertebral body (L3 and L5) and tibial plateau
(n.2). All the lesions were diagnosed by plain films, CT
and MRI and controlled after the procedure by MRI and
CT. The clinical evaluation was performed by VAS scale.
Results
All the patients but one treated with RF termoablation
showed a regression in painful symptomatology with a
mean VAS decreasing from 8 to 1.2 two years after the
treatment. The treatment with MRgFUS was successful
in 11 out of 13 patients (mean VAS dropped from 8.1 to
1.3 two years after the treatment). The two cases unre-
sponsive were re-treated successfully with RF. The MRI
evaluation showed a disappearance of bone edema
already to the first controls at 6 months after the treat-
ment in all the patients treated successfully. In the CT
controls no substantial changes were found, except for
the disappearance of the central calcification of the nidus
in the 40% of cases treated with MRgFUS.
Conclusion
Although further studies with a longer term and a larger
number of cases are needed, our experience demonstrates
the effectiveness of the treatment of osteoid osteomas with
MRgFUS. In particular this treatment is successful in the
84,6% of cases. The main limit is today represented by the
accessibility of the lesion by the ultrasound. However the
treatment is repeatable and does not preclude treatments
with other techniques.
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